Emily J Lelliott

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Top Venues

NPJ precision oncology

Cell death and differentiation

Cancer immunology research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Emily J Lelliott, Jonathan Naddaf, Katherine Ganio, Jessica Michie, Shelly Wang, Lin Liu, Natasha Silke, Antonio Ahn, Kelly M Ramsbottom, Amelia J Brennan, Andrew J Freeman, Shom Goel, Stephin J Vervoort, Conor J Kearney, Paul A Beavis, Christopher A McDevitt, John Silke, Jane Oliaro
Intracellular zinc protects tumours from T cell-mediated cytotoxicity. Cell death and differentiation (2024)
Emily J Lelliott, Karen E Sheppard, Grant A McArthur
Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything? NPJ precision oncology 6 (1) (2022)
Emily J Lelliott, Isabella Y Kong, Magnus Zethoven, Kelly M Ramsbottom, Luciano G Martelotto, Deborah Meyran, Joe Jiang Zhu, Matteo Costacurta, Laura Kirby, Jarrod John Sandow, Lydia Lim, Pilar M Dominguez, Izabela Todorovski, Nicole M Haynes, Paul A Beavis, Paul J Neeson, Edwin D Hawkins, Grant A McArthur, Ian A Parish, Ricky W Johnstone, Jane Oliaro, Karen E Sheppard, Conor J Kearney, Stephin J Vervoort
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory. Cancer discovery 11 (10) (2021)
Emily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, Magnus Zethoven, Lydia Lim, Peter Kar Han Lau, Amanda J Oliver, Luciano G Martelotto, Laura Kirby, Claire Martin, Riyaben P Patel, Alison Slater, Carleen Cullinane, Anthony T Papenfuss, Nicole M Haynes, Grant A McArthur, Jane Oliaro, Karen E Sheppard
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma. Cancer immunology research 9 (2) (2020)